Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schedel, J
Right arrow Articles by Gay, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schedel, J
Right arrow Articles by Gay, S
Annals of the Rheumatic Diseases 2004;63:1205-1211
© 2004 by BMJ Publishing Group Ltd & European League Against Rheumatism


EXTENDED REPORT

Discrepancy between mRNA and protein expression of tumour suppressor maspin in synovial tissue may contribute to synovial hyperplasia in rheumatoid arthritis

J Schedel 1,2, O Distler 2, M Woenckhaus 3, R E Gay 2, B Simmen 4, B A Michel 2, U Müller-Ladner 1, S Gay 2

1 Department of Internal Medicine I, Division of Rheumatology and Clinical Immunology, University Hospital of Regensburg, D-93053 Regensburg, Germany
2 Centre of Experimental Rheumatology and WHO Collaborating Centre for Molecular Biology and Novel Therapeutic Strategies for Rheumatic Diseases, Department of Rheumatology, University Hospital of Zurich, CH-8091 Zurich, Switzerland
3 Department of Pathology, University Hospital of Regensburg, D-93053 Regensburg, Germany
4 Department of Orthopaedic Surgery, Schulthess Hospital, CH-8006 Zurich, Switzerland

Correspondence to:
Correspondence to:
Dr J Schedel
Department of Internal Medicine I, Division of Rheumatology and Clinical Immunology, University Hospital of Regensburg, D-93042 Regensburg, Germany; joerg.schedel{at}klinik.uni-regensburg.de

Objective: To investigate the expression of maspin in RA synovial tissue and compare it with the expression in osteoarthritis (OA) and normal synovial tissue (NS).

Methods: Using specific primers for maspin, a 237 bp fragment was amplified from cDNA obtained from cultured RA, OA, and normal synovial fibroblasts (SF) by RT-PCR. Additionally, mRNA expression levels were determined quantitatively by real time PCR. mRNA expression of maspin was investigated on snap frozen and paraffin embedded synovial tissue sections by in situ hybridisation. Immunohistochemistry was used to identify the cell type expressing maspin. SDS-PAGE and western blotting were performed to evaluate the protein expression in cultured SF. To confirm protein synthesis in situ, immunohistochemistry with specific anti-maspin antibodies was performed in synovial tissue sections of patients with RA.

Results: RT-PCR showed expression of maspin in all cDNA samples from cultured SF. Maspin mRNA was found to be decreased in RA SF twofold and 70-fold compared with OA SF and NS SF, respectively. Maspin mRNA was expressed in RA, OA, and normal synovial tissue. Importantly, maspin transcripts were also found at sites of invasion into cartilage and bone. At the protein level, maspin could be detected in RA and, less prominently, OA SF. In RA synovial tissue, maspin protein was detected in only a few synovial lining cells.

Conclusion: Maspin is expressed intensively in RA SF at the mRNA level, but only slightly at the protein level, possibly owing to down regulation of maspin; this may contribute to the hyperplasia of synovial tissue in RA.


Abbreviations: maspin, mammary serine protease inhibitor; NS, normal synovial tissue; OA, osteoarthritis; PAI, plasminogen activator inhibitor; RA, rheumatoid arthritis; RT-PCR, reverse transcriptase-polymerase chain reaction; SDS-PAGE, sodium dodecyl sulphate-polymerase gel electrophoresis; SF, synovial fibroblasts; uPA, urokinase plasminogen activator

Keywords: maspin; rheumatoid arthritis; synovial fibroblasts; synovial hyperplasia; tumour suppressor genes




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
Z. Khalkhali-Ellis
Maspin: The New Frontier
Clin. Cancer Res., December 15, 2006; 12(24): 7279 - 7283.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
W. J. Brackenbury and M. B. A. Djamgoz
Activity-dependent regulation of voltage-gated Na+ channel expression in Mat-LyLu rat prostate cancer cell line
J. Physiol., June 1, 2006; 573(2): 343 - 356.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
L. Tong, R. M. Corrales, Z. Chen, A. L. Villarreal, C. S. De Paiva, R. Beuerman, D.-Q. Li, and S. C. Pflugfelder
Expression and Regulation of Cornified Envelope Proteins in Human Corneal Epithelium
Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1938 - 1946.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 BMJ Publishing Group Ltd & European League Against Rheumatism